Cargando…
NEW ONSET ATRIAL TACHYCARDIA AND GUILLAIN-BARRE SYNDROME AFTER MONOCLONAL ANTIBODY THERAPY FOR COVID-19
Autores principales: | Lewis, Antonio, Dev, Jenakan, Sleiman, Jose, Sarkar, Abdullah, Sanchez, Alejandro, Uppal, Dipan, Nimmagadda, Manojna, Miranda, Diana, Perez, Eduardo Javier, Asher, Craig R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972353/ http://dx.doi.org/10.1016/S0735-1097(22)03507-0 |
Ejemplares similares
-
Atrial Fibrillation and Ventricular Tachycardia in a Patient with Cardiac Sarcoidosis
por: Lau, Joanne, et al.
Publicado: (2018) -
Patent Foramen Ovale as a Rare Focus of Origination of Atrial Tachycardia
por: Tan, Jian L., et al.
Publicado: (2019) -
Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
por: Rajabally, Yusuf A.
Publicado: (2022) -
Guillain-Barré syndrome and COVID-19: association or coincidence
por: Gale, Aislinn, et al.
Publicado: (2020) -
Zero-fluoroscopy Radiofrequency Redo Ablation of Atrial Tachycardia Following Pulmonary Vein Isolation: A Tale of Two Systems
por: Percell, Robert L., et al.
Publicado: (2018)